Impact of renin–angiotensin–aldosterone system inhibitors on COVID-19
Yasushi Matsuzawa, Kazuo Kimura, Hisao Ogawa, Kouichi Tamura
Topics & Concepts
Renin–angiotensin systemCoronavirus disease 2019 (COVID-19)MedicineCoronavirusAngiotensin-converting enzyme 2Angiotensin IISevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ReceptorInternal medicinePharmacologyImmunologyEndocrinologyDiseaseInfectious disease (medical specialty)Blood pressureCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19COVID-19 and Mental Health